Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-03-22 @ 9:03 AM
Study NCT ID:
NCT01634893
Status:
COMPLETED
Last Update Posted:
2016-03-25
First Post:
2012-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CTRC 11-71
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None